About NCTA2022-02-28T18:00:55+00:00

About NCTA

NCTA is a nationwide coalition of leading, independent community oncology practices that help employers improve cancer care. The Community Oncology Alliance (COA) created NCTA to contract directly with employers for cancer treatments, which ensures employees have access to the highest-quality, most affordable local cancer care.

As many cancer drugs are available in oral form, and prescription drug benefits are a source of excessive cost and aggravation, the NCTA’s first contracting subsidiary is the Cancer Pharmacy Network (CPN). Functioning as a clinically integrated network, the CPN will provide direct contracting for oral cancer drugs between oncology providers and employers, as well as data-backed informational studies that help shed light and transparency on the opaque world of PBM contracting, rebates, and exclusionary pharmacy networks.

NCTA is also leveraging the expertise of its national oncology network to provide information, resources, and educational materials on key issues in cancer care to employers and employees, ranging from fundamental education on molecular and genetic testing; the importance and value of biosimilars; and understanding and assessing cancer care costs and quality.

Leadership

Robert Baird, RN, MSA
Robert Baird, RN, MSAPresident
Carrie Pernell
Carrie PernellDirector of Operations

Why NCTA?

Employers are the largest cancer care payer for people under the age of 65. For years, they have sought solutions that provide high-quality care, exceptional patient experience, and affordability. Yet it has become increasingly difficult to navigate cancer treatment, and health care costs continue to rise.

NCTA helps employers by contracting directly with them for cancer treatments so their employees have access to the highest-quality, locally accessible, and most affordable cancer care. NCTA’s national network of community oncology providers help employers and employees better understand key issues in cancer such as the value of diagnostic and genetic testing, the role of new immunotherapies, and the equivalency of biosimilars.

Frequently Asked Questions

Is NCTA up and running?2020-05-21T14:48:14+00:00

Yes. NCTA is fully functional and will continue to add more educational resources on key issues in cancer in the coming months. It has begun to build its first subsidiary, CPN, which will provide direct contracting for oral cancer drugs and data-driven informational studies to promote transparency around the cost of care.

Has NCTA engaged employers in the organization’s development?2020-05-21T14:49:04+00:00

Yes. The NCTA team spoken with dozens of employers and health care purchasing organizations across the country. They learned that there is a tremendous need for innovations that put employers and employees first: boosting quality and improve patients’ experience with cancer care and reducing costs.

Is NCTA membership open exclusively to members of COA?2020-05-21T14:49:49+00:00

No. NCTA membership is open to all high-performing oncology practices in the United States. Practices don’t have to be a member of COA to join NCTA, but must be committed to delivering affordable, high-quality, and locally accessible cancer care to employers and their employees.

How is NCTA related to CPN?2020-05-21T14:50:21+00:00

NCTA is creating CPN, its first subsidiary, to provide direct contracting for oral cancer drugs and data-driven informational studies that promote transparency around the cost of care. As a clinically integrated network, CPN will allow community oncology practices around the country to work together toward employers’ shared goals of providing employees high-quality, affordable cancer care.

How can NCTA and CPN improve upon a broken drug benefits system dominated by large PBMs?2020-05-21T14:50:51+00:00

For decades, employers have utilized pharmacy benefit managers (PBMs) with little to show for it. NCTA and CPN will create transparency in drug benefit design and delivery where there currently is none and a first-rate treatment experience for patients.

Go to Top